Skip to main content

Genetic modification.

The insurance industry's decision to finally agree to a five year moratorium on the use of genetic tests provides the industry with an opportunity to resolve the issues to the benefit of all concerned, argues Tony O'Leary.

This year has been a turning point on the debate concerning the use
of genetic information in the insurance underwriting process.


It is a debate that has been ongoing for the past decade and has now

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Register

Want to know what’s included in our free registration? Click here

Already have an account? Sign in here

Show password
Hide password

Tara Foley, Axa

Tara Foley’s leadership of Axa UK & Ireland is defined by a commitment to showing how general insurance can protect all sectors of society.

Drazen Jaksic, Zurich

Drazen Jaksic climbs higher on this year’s Insurance Post Power List as the takeover of Beazley sees his influence expanding further into the London market.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here